Pyrazines (administration & dosage) < Pyrazines (adverse effects) < Pyrazines (blood)

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f Mesh.f MeshFr.f KwdFr.f

List of bibliographic references indexed by Pyrazines (adverse effects)

Number of relevant bibliographic references: 7.

Ident.	Authors (with country if any)	Title
000020 (2021)	Fabio Cruciani [Italie] ; Laura Amato [Italie] ; Franco De Crescenzo ; Zuzana Mitrova [Italie] ; Rosella Saulle [Italie] ; Simona Vecchi [Italie] ; Marina Davoli [Italie]	[The praise of uncertainty: a systematic living review to evaluate the efficacy and safety of drug treatments for patients with covid-19.]
000158 (2021)	Hany M. Dabbous [Égypte] ; Manal H. El-Sayed [Égypte] ; Gihan El Assal [Égypte] ; Hesham Elghazaly [Égypte] ; Fatma F S. Ebeid [Égypte] ; Ahmed F. Sherief [Égypte] ; Maha Elgaafary [Égypte] ; Ehab Fawzy [Égypte] ; Sahar M. Hassany [Égypte] ; Ahmed R. Riad [Égypte] ; Mohamed A. Tageldin [Égypte]	Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial.
000297 (2021)	Havva Kocayi It [Turquie] ; Kezban Özmen Süner [Turquie] ; Yakup Tomak [Turquie] ; Gürkan Demir [Turquie] ; Selçuk Yaylac [Turquie] ; Hamad Dheir [Turquie] ; Ertu Rul Güçlü [Turquie] ; Ali Fuat Erdem [Turquie]	Observational study of the effects of Favipiravir vs Lopinavir/Ritonavir on clinical outcomes in critically Ill patients with COVID-19.
000807 (2020)	Melanie Bilbul [États-Unis] ; Patricia Paparone [États-Unis] ; Anna M. Kim [États-Unis] ; Shruti Mutalik [États-Unis] ; Carrie L. Ernst [États-Unis]	Psychopharmacology of COVID-19.
000867 (2020)	Saleh A. Alqahtani [Arabie saoudite, États-Unis] ; Abdulrahman A. Aljumah [Arabie saoudite] ; Almoutaz Hashim [Arabie saoudite] ; Thamer H. Alenazi [Arabie saoudite] ; Mohammed Aljawad ; Waleed K. Al Hamoudi [Arabie saoudite] ; Mohammed Y. Alghamdi [Arabie saoudite]	Principles of Care for Patients with Liver Disease During the Coronavirus Disease 2019 (COVID-19) Pandemic: Position Statement of the Saudi Association for the Study of Liver Disease and Transplantation.
001897 (2020)	Paul Gougis [France] ; Charlotte Fenioux [France] ; Christian Funck-Brentano [France] ; Marianne Veyri [France] ; Joseph Gligorov [France] ; Caroline Solas [France] ; Jean-Philippe Spano [France]	Anticancer drugs and COVID-19 antiviral treatments in patients with cancer: What can we safely use?
001A01 (2020)	Mohammad Bosaeed [Arabie saoudite] ; Ebrahim Mahmoud [Arabie saoudite] ; Mohammad Hussein [Arabie saoudite] ; Ahmad Alharbi [Arabie saoudite] ; Abdulrahman Alsaedy [Arabie saoudite] ; Adel Alothman [Arabie saoudite] ; Majed Aljeraisy [Arabie saoudite] ; Hajar Alqahtani [Arabie saoudite] ; Marwan Nashabat [Arabie saoudite] ; Badriah Almutairi [Arabie saoudite] ; Manar Almaghaslah [Arabie saoudite] ; Omar Aldibasi [Arabie saoudite] ; Sameera Aljohani [Arabie saoudite] ; Abderrezak Bouchama [Arabie saoudite] ; Yaseen Arabi [Arabie saoudite] ; Ahmad Alaskar [Arabie saoudite]	A Trial of Favipiravir and Hydroxychloroquine combination in Adults Hospitalized with moderate and severe Covid-19: A structured summary of a study protocol for a randomised controlled trial.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Pyrazines (adverse effects)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Pyrazines (adverse effects)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Pyrazines (adverse effects)
}}

---

This area was generated with Dilib version V0.6.38. Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021